CJC 1295 No DAC – 5mg (10 vials)

CJC-1295 No DAC – 5mg – 10 Vials

Product Overview

CJC-1295 No DAC is a synthetic peptide commonly associated with the name Mod GRF (1-29). It is based on the first 29 amino acids of growth hormone-releasing hormone (GHRH) and has been studied for its interaction with GHRH receptors.

The No DAC designation indicates that this version does not contain the Drug Affinity Complex modification found in CJC-1295 with DAC. The distinction is important because the two forms have different structural characteristics and circulation profiles.

Product Details

• Product Name: CJC-1295 No DAC
• Alternative Name: Mod GRF (1-29)
• Listed Strength: 5mg
• Package Quantity: 10 vials
• Product Category: Synthetic Peptide
• Research Area: GHRH receptor activity and growth hormone signaling
• DAC Modification: Not included
• Manufacturer: Confirm with supplier
• Formulation: Confirm with supplier
• Storage Requirements: Follow verified manufacturer documentation

Scientific Background

GHRH is a naturally occurring hormone involved in regulating growth hormone release from the pituitary gland. CJC-1295 No DAC has been investigated in relation to this signaling pathway.

Unlike the DAC-modified form, the No DAC version does not include the modification intended to extend circulation time. Product identity should be confirmed through supplier specifications before relying on research references associated with Mod GRF (1-29).

Product Verification

Before publishing or distributing this product, confirm:

• Whether 5mg refers to each vial or the complete package
• That the product is the No DAC form
• Exact peptide identity and supplier specifications
• Manufacturer identity and product labeling
• Batch identification and available quality documentation
• Storage and handling requirements
• Applicable regulatory status and distribution requirements

Important Safety and Regulatory Information

CJC-1295 No DAC is an investigational peptide. Its safety and effectiveness for therapeutic human use have not been established sufficiently to present it as an approved treatment.

This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Verify the product’s identity and regulatory status before publication.